title: Immunohistological analysis of in-transit metastasis in a patient with advanced melanoma treated with combination therapy of cytosine guanine dinucleotide oligodeoxynucleotide, dacarbazine and beta-interferon: a case report.
authors.forename: Akiko
authors.initials: A
authors.lastname: Ozawa
authors.forename: Tomoko
authors.initials: T
authors.lastname: Nomiyama
authors.forename: Noriaki
authors.initials: N
authors.lastname: Nakai
authors.forename: Gunther
authors.initials: G
authors.lastname: Hartmann
authors.forename: Hideya
authors.initials: H
authors.lastname: Takenaka
authors.forename: Saburo
authors.initials: S
authors.lastname: Kishimoto
authors.forename: Norito
authors.initials: N
authors.lastname: Katoh
mesh_terms: D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage; D015226:Dinucleoside Phosphates / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000008:administration & dosage; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000737:chemistry*
chemical_list: D003606:Dacarbazine; D015226:Dinucleoside Phosphates; D016899:Interferon-beta; C015772:CpG dinucleotide